Day: August 27, 2020

PARIS, Aug. 27, 2020 (GLOBE NEWSWIRE) — Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), in particular against rare or resistant cancers, today reported the publication in the British Journal of Cancer of the final results of its DRIIV Phase 1 dose escalation study of AsiDNA™, the Company’s first-in-class DDR inhibitor, administered intravenously (IV). DRIIV was instrumental in demonstrating the good safety profile and activity of AsiDNA™ via the IV route. The active dose of 600 mg was determined to be the optimal dose for use in combination and is currently being used in the evaluation of AsiDNA™ in combination with chemotherapies (DRIIV-1b study) and a PARP inhibitor...

Please find attached the Half Yearly Report for BGHLAttachmentBGAM BGHL – Financials 30 June 2020 typesigned

NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) — Hennessy Capital Acquisition Corp. IV (“HCAC”) (NASDAQ: HCAC) announced today that its stockholders approved an extension of the date by which it has to complete a business combination from September 5, 2020 to December 31, 2020. HCAC requested the extension in order to complete the previously announced proposed business combination (the “Canoo Transaction”) with Canoo Holdings Ltd. (“Canoo”), a company developing breakthrough electric vehicles.The Canoo Transaction is expected to be completed in the fourth quarter of 2020, subject to, among other things, the approval by HCAC stockholders and the satisfaction or waiver of other customary closing conditions set forth in the definitive agreement for the Canoo Transaction.About HCACHennessy Capital Acquisition Corp. IV is a special purpose...

Please find attached the Half Yearly ReportAttachmentBGAM BGHL – Financials 30 June 2020 typesigned

Highlights of Q2 2020 resultsRevenues amounted to EUR 160.6 million, a decrease of EUR 6.9 million or 4.1% when compared with the same quarter in 2019.Revenues mainly affected by a 5.3% lower volume in liner services and EUR 4.0 million lower contribution of services in Iceland because of weakening of the ISK.Forwarding volume was down by 5.3% however, revenues increased by 3.5% mainly due to higher share of reefer cargo.Total expenses amounted to EUR 144.6 million, a decrease of EUR 7.1 million, compared with the same quarter in 2019, mainly driven by realization of streamlining measures.Reduction in salary expenses by EUR 4.0 million or 11.9% whereof EUR 2.0 million related to devaluation of ISK. EUR 1.0 million redundancy cost included in salaries.Savings in sailing system expenses, administrative expenses and lower fuel prices contributed...

Helstu atriði í afkomu annars ársfjórðungsTekjur námu 160,6 milljónum evra og lækkuðu um 6,9 milljónir evra eða 4,1% frá sama ársfjórðungi 2019.Lækkun tekna má fyrst og fremst rekja til 5,3% samdráttar í magni í siglingakerfinu og 4,0 milljóna evra lægri tekna í starfsemi á Íslandi vegna veikingar krónunnar.Magn í flutningsmiðlun minnkaði um 5,3% en hins vegar jukust tekjur um 3,5% vegna hærra hlutfalls frystiflutninga.Kostnaður nam 144,6 milljónum evra sem er lækkun um 7,1 milljón evra milli tímabila sem skýrist að mestu af hagræðingaraðgerðum sem eru að skila sér.Launakostnaður lækkaði um 4,0 milljónir evra eða 11,9%, þar af 2,0 milljónir evra vegna veikingar krónunnar. Uppsagnarkostnaður að fjárhæð 1,0 milljón evra meðtalinn í launum.  Kostnaðarlækkun í siglingakerfi, stjórnunarkostnaði og olíuverði höfðu áhrif til lækkunar á kostnaði.Þegar...

SALT LAKE CITY, Aug. 27, 2020 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) announced today that Darren Jensen, the Company’s President and Chief Executive Officer and Steve Fife, Chief Financial Officer, will participate in two upcoming investor conferences virtually.  These include the LD Micro 500, to be held September 1-4, 2020 and the H.C. Wainwright 22nd Annual Global Investment Conference to be held September 14-16.At the LD Micro 500, Mr. Jensen and Mr. Fife will meet with investors and participate in a virtual presentation at 9:20 a.m. Mountain Time (11:20 a.m. Eastern Time) on Wednesday, September 2, 2020. The webcast of their presentation will be available on the Investor Relations – Events and Presentations section of the Company’s website at http://investor.lifevantage.com/events-and-presentations...

WILLIAMSVILLE, N.Y., Aug. 27, 2020 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based life science company driven by next generation plant biotechnology, today announced that the Company’s executive management team will present at the LD Micro 500 Virtual Conference on Thursday, September 3, 2020 at 4:20 p.m. ET and will be available for one-on-one meetings with investors throughout the day on September 3 and 4, 2020.The live webcast and presentation will be accessible in the Investors section of 22nd Century’s website under Events. An archived replay of the webcast will be available shortly after the live event.Please visit https://ld500.ldmicro.com/ to register for the conference.About 22nd Century Group, Inc.22nd Century Group, Inc. (NYSE American: XXII)...